A risk of transcranial magnetic stimulation is eliciting of a grand mal seizure. After the failure to demonstrate its psychiatric benefits, the researchers now exploit this risk as a clinical technique. They offer magnetically induced grand mal seizures, hoping that the benefits will match those of ECT with lesser effects on memory. This hope, however, is inconsistent with the 70 years of experimentation with convulsive therapy. Seizures have been induced with intramuscular camphor or insulin, intravenous pentylenetetrazol, the inhalant flurothyl, and electrically. When full grand mal seizures are induced by any method, the behavioral effects are demonstrable, as are accompanying transient memory effects. An extensive experience with the asymmetric and partial seizures induced with unilateral electrode placement found seizures with lesser cognitive effects to have lesser clinical benefits (6). Among stimulation techniques, ECT dominates clinical practice today, not for any specific benefit or lesser risk associated with electricity but for ease of use, least expense, and least discomfort to patients. Magnetic seizure therapy may, in time, emulate ECT, but it is improbable that it will be as easy and as inexpensive as electrical inductions.